Press Releases April 23, 2026 04:05 PM

Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast

Definitive Healthcare Announces Q1 2026 Financial Results Release and Conference Call on May 7, 2026

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
DH

Definitive Healthcare Corp., a leading healthcare market data and analytics company, announced it will release its first quarter 2026 financial results on May 7, 2026, after market close. A conference call and webcast will be held to discuss the results with investors and analysts.

Definitive Healthcare Announces Timing of Its First Quarter 2026 Financial Results Conference Call and Webcast
DH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Definitive Healthcare to report Q1 2026 financial results on May 7, 2026.
  • Company will host a conference call and webcast at 5 PM ET to discuss the results.
  • Definitive Healthcare is focused on healthcare market data and analytics, serving healthcare organizations and companies.

FRAMINGHAM, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results.

A live audio webcast of the event will be available on the Definitive Healthcare’s Investor Relations website at https://ir.definitivehc.com/.

A live dial-in will be available at 877-358-7298 (domestic) or +1-848-488-9244 (international). Shortly after the conclusion of the call, a replay of this conference call will be available through June 6, 2026 at 800-645-7964 or 757-849-6722. The replay passcode is 1765#.

About Definitive Healthcare
Definitive Healthcare is a data and analytics company focused on the business side of healthcare. The healthcare market is complex — our data makes it clearer. We cut through the noise to deliver the insights that healthcare organizations and companies need to make smarter, faster, more strategic decisions. Because when our customers succeed, healthcare gets better for everyone. Learn more at definitivehc.com.

Media Contact:
Bethany Swackhamer
bswackhamer@definitivehc.com

Investor Relations Contact:
Brian Denyeau
ICR for Definitive Healthcare
brian.denyeau@icrinc.com

Source: Definitive Healthcare Corp.


Risks

  • Financial results may differ from market expectations, potentially impacting stock price volatility.
  • Broader economic or healthcare sector developments could influence company performance and investor sentiment.
  • Dependence on the healthcare industry’s data demand and the company’s ability to maintain competitive advantage.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026